Home WakeSpace Scholarship › Electronic Theses and Dissertations

Genetic Sequencing in Healthy Populations

Electronic Theses and Dissertations

Item Files

Item Details

abstract
After the success of the Human Genome Project, genetic sequencing technology has improved exponentially. Consumers can now have parts of their genome sequenced for under $100. Genetic sequencing in this direct-to-consumer (DTC) setting comes with many ethical problems that, despite being brought to national attention almost ten years ago, still have not been addressed. Significant regulation is needed in DTC genetic sequencing. As genetic sequencing becomes more widely available, Whole Genome Sequencing (WGS) will move into the clinical space, providing massive amounts of information about patients. Many have suggested using this technology in the standard screening of healthy populations. This brings ethical dilemmas as well, particularly when considering the use of WGS in fetuses, infants, and children. While WGS may be acceptable for use in adults if adequate safeguards are put into place, parents have a moral duty, based on the child’s right to future autonomy and right not to know genetic information, not to permit WGS to be performed on their children.
subject
direct-to-consumer genetic testing
ethics
genetic screening
genetic testing
newborn screening
whole genome sequencing
contributor
Sells, Samantha E. (author)
King, Nancy (committee chair)
Hall, Mark (committee member)
Coughlin, Christine (committee member)
date
2018-05-24T08:35:46Z (accessioned)
2018-05-24T08:35:46Z (available)
2018 (issued)
degree
Bioethics (discipline)
identifier
http://hdl.handle.net/10339/90687 (uri)
language
en (iso)
publisher
Wake Forest University
title
Genetic Sequencing in Healthy Populations
type
Thesis

Usage Statistics